Melanoma Treatment: TILT-123 and Chemotherapy

We are studying a new oncolytic virus treatment combined with chemotherapy for patients with melanoma. This trial aims to see if this combination can improve treatment outcomes.

>2 yearsSafety phase (I)DermatologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Region Hovedstaden
Department of Oncology
Rødovre, Denmark
Sponsor: TILT Biotherapeutics Oy
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.